Primacy of hepatic insulin resistance in the development of the metabolic syndrome induced by an isocaloric moderate-fat diet in the dog

Diabetes

Volumn 52, Issue 10, 2003, Pages 2453-2460

  Kim, Stella P ^b   Ellmerer, Martin ^b   Van Citters, Gregg W ^b   Bergman, Richard N ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FAT; INSULIN;

ANIMAL EXPERIMENT; ARTICLE; CALORIC INTAKE; CONTROLLED STUDY; DOG; FAT CONTENT; FAT INTAKE; GLUCONEOGENESIS; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HORMONE ACTION; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; MALE; METABOLIC DISORDER; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PRIORITY JOURNAL; STEADY STATE; SUBCUTANEOUS FAT;

ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; BODY COMPOSITION; DIETARY FATS; DOGS; ENERGY INTAKE; FASTING; FATTY ACIDS, NONESTERIFIED; GLUCOSE; INSULIN; INSULIN RESISTANCE; LIVER; MALE; METABOLIC SYNDROME X;

EID: 0141532189     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.52.10.2453     Document Type: Article

References (50)

1. Kissebah AH: Central obesity: measurement and metabolic effects. Diabetes Reviews 5:8-20, 1997
2. Zimmet P, Alberti, KGMM, Shaw J: Global and societal implications of the diabetes epidemic. Nature 414:782-787, 2001
3. Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S: The metabolically obese, normal-weight individual revisited (Review). Diabetes 47:699-713, 1998
4. Park KS, Rhee BD, Lee KU, Kim SY, Lee HK, Koh CS, Min HK: Intraabdominal fat is associated with decreased insulin sensitivity in healthy young men. Metabolism 40:600-603, 1991
5. Bergstrom RW, Newell-Morris LL, Leonetti DL, Shuman WP, Wahl PW, Fujimoto WY: Association of elevated fasting C-peptide level and increased intra-abdominal fat distribution with development of NIDDM in Japanese-American men. Diabetes 39:104-111, 1990
6. Deurenberg P, Yap M, van Staveren WA: Body mass index and percent body fat: a meta analysis among different ethnic groups. Int J Obes Relat Metab Disord 22:1164-1171, 1998
7. Kissebah AH, Peiris AN: Biology of regional body fat distribution: relationship to non-insulin-dependent diabetes mellitus. Diabetes Metab Rev 5:83-109, 1989
8. McTernan PG, McTernan CL, Chetty R, Jenner K, Fisher FM, Lauer MN, Crocker J, Barnett AH, Kumar S: Increased resistin gene and protein expression in human abdominal adipose tissue. J Clin Endocrinol Metab 87:2407, 2002
9. Greenberg AS, McDaniel ML: Identifying the links between obesity, insulin resistance and beta-cell function: potential role of adipocyte-derived cytokines in the pathogenesis of type 2 diabetes. Eur J Clin Invest 32 (Suppl. 3):24-34, 2002
10. Barzilal N, She L, Liu L, Wang J, Hu M, Vuguin P, Rossetti L: Decreased visceral adiposity accounts for leptin effect on hepatic but not peripheral insulin action. Am J Physiol 277:E291-E298, 1999
11. Mittelman SD, Van Citters GW, Kim SP, Davis DA, Dea MK, Hamilton-Wessler M, Bergman RN: Longitudinal compensation for fat-induced insulin resistance includes reduced insulin clearance and enhanced beta-cell response. Diabetes 49:2116-2125, 2000
12. Pan DA, Lillioja S, Kriketos AD, Milner MR, Baur LA, Bogardus C, Jenkins AB, Storlien LH: Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 46:983-988, 1997
13. Rocchini AP, Marker P, Cervenka T: Time course of insulin resistance associated with feeding dogs a high-fat diet. Am J Physiol 272: E147-E154, 1997
14. Finegood DT, Bergman RN, Vranic M: Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps: comparison of unlabeled and labeled exogenous glucose infusates. Diabetes 36:914-924, 1987
15. Rebrin K, Steil GM, Getty L, Bergman RN: Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes 44:1038-1045, 1995
16. Bradley DC, Steil GM, Bergman RN: OOPSEG: a data smoothing program for quantitation and isolation of random measurement error. Comput Methods Programs Biomed 46:67-77, 1995
17. Paquot N, Scheen AJ, Dirlewanger M, Lefebvre PJ, Tappy L: Hepatic insulin resistance in obese non-diabetic subjects and in type 2 diabetic patients. Obes Res 10:129-134, 2002
18. Carey DG, Jenkins AB, Campbell LV, Freund J, Chisholm DJ: Abdominal fat and insulin resistance in normal and overweight women: direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes 45:633-638, 1996
19. Kim JK, Wi JK, Youn JH: Metabolic impairment precedes insulin resistance in skeletal muscle during high-fat feeding in rats. Diabetes 45:651-658, 1996
20. Oakes ND, Cooney GJ, Camilleri S, Chisholm DJ, Kraegen EW: Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding. Diabetes 46:1768-1774, 1997
21. Kraegen EW, Clark PW, Jenkins AB, Daley EA, Chisholm DJ, Storlien LH: Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats. Diabetes 40:1397-1403, 1991
22. Kissebah AH, Krakower GR: Regional adiposity and morbidity. Physiol Rev 74:761-811, 1994
23. DeNino WF, Tchernof A, Dionne IJ, Toth MJ, Ades PA, Sites CK, Poehlman ET: Contribution of abdominal adiposity to age-related differences in insulin sensitivity and plasma lipids in healthy nonobese women. Diabetes Care 24:925-932, 2001
24. Lewis GF, Vranic M, Giacca A: Role of free fatty acids and glucagon in the peripheral effect of insulin on glucose production in humans. Am J Physiol 275:E177-E186, 1998
25. Boden G: Role of fatty acids in the pathogenesis of insulin resistance and NIDDM (Review). Diabetes 46:3-10, 1997
26. Rebrin K, Steil G, Mittelman SD, Bergman RN: Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs. J Clin Invest 98:741-749, 1996
27. Boden G, Chen X: Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes. J Clin Invest 96:1261-1268, 1995
28. Meek SE, Nair KS, Jensen MD: Insulin regulation of regional free fatty acid metabolism. Diabetes 48:10-14, 1999
29. Mittelman SD, Van Citters GW, Kirkman EL, Bergman RN: Extreme insulin resistance of the central adipose depot in vivo. Diabetes 51:755-761, 2002
30. Arner P: Not all fat is alike. Lancet 351:1301-1302, 1998
31. Guo Z, Hensrud DD, Johnson CM, Jensen MD: Regional postprandial fatty acid metabolism in different obesity phenotypes. Diabetes 48:1586-1592, 1999
32. Gonzalez-Manchon C, Ayuso MS, Parrilla R: Control of hepatic gluconeogenesis: role of fatty acid oxidation. Arch Biochem Biophys 271:1-9, 1989
33. Landau BR: Methods for measuring glycogen cycling. Am J Physiol Endocrinol Metab 281:E413-E419, 2001
34. Boden G, Cheung P, Stein TP, Kresge K, Mozzoli M: FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis. Am J Physiol Endocrinol Metab 283:E12-E19, 2002
35. Petersen KF, Laurent D, Rothman DL, Cline GW, Shulman GI: Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans. J Clin Invest 101:1203-1209, 1998
36. Shulman GI: Cellular mechanisms of insulin resistance. J Clin Invest 106:171-176, 2000
37. Kim JK, Fillmore JJ, Chen Y, Yu C, Moore IK, Pypaert M, Lutz EP, Kako Y, Velez-Carrasco W, Goldberg IJ, Breslow JL, Shulman GI: Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc Natl Acad Sci U S A 98:7522-7527, 2001
38. Ryysy L, Hakkinen AM, Goto T, Vehkavaara S, Westerbacka J, Halavaara J, Yki-Jarvinen H: Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes 49:749-758, 2000
39. Seppala-Lindroos A, Vehkavaara S, Hakkinen AM, Goto T, Westerbacka J, Sovijarvi A, Halavaara J, Yki-Jarvinen H: Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 87:3023-3028, 2002
40. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G: Adipose tissue necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 280:E745-E751, 2001
41. Tsigos C, Kyrou I, Chala E, Tsapogas P, Stavridis JC, Raptis SA, Katsilambros N: Circulating tumor necrosis factor alpha concentrations are higher in abdominal versus peripheral obesity. Metabolism 48:1332-1335, 1999
42. Fried SK, Bunkin DA, Greenberg AS: Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 83:847-850, 1998
43. Kanemaki T, Kitade H, Kaibori M, Sakitani K, Hiramatsu Y, Kamiyama Y, Ito S, Okumura T: Interleukin 1beta and interleukin 6, but not tumor necrosis factor alpha, inhibit insulin-stimulated glycogen synthesis in rat hepatocytes. Hepatology 27:1296-1303, 1998
44. Lang CH, Dobrescu C, Bagby GJ: Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology 130:43-52, 1992
45. Cheung AT, Wang J, Ree D, Kolls JK, Bryer-Ash M: Tumor necrosis factor-alpha induces hepatic insulin resistance in obese Zucker (fa/fa) rats via interaction of leukocyte antigen-related tyrosine phosphatase with focal adhesion kinase. Diabetes 49:810-819, 2000
46. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S, Coppack SW: Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo. J Clin Endocrinol Metab 82:4196-4200, 1997
47. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:79-83, 1999
48. Berg AH, Combs TP, Du X, Brownlee M, Scherer P: The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7:947-953, 2001
49. Fruebis J, Tsao TS, Javorschi S, Ebbets-Reed D, Erickson MR, Yen FT, Bihain BE, Lodish HF: Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A 98:2005-2010, 2001
50. Saltiel AR: You are what you secrete. Nat Med 7:887-888, 2001